Clinical Trial Update: Botensilimab, Balstilimab, and SBRT in Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase study evaluating botensilimab, balstilimab, and SBRT in non-MSI-H or pMMR colorectal cancer with liver metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING